[Fractal Trader]

This is just sour grapes from the regulatory world. This article is nothing new.

Any practitioner will tell you that Neurontin is a highly effective drug for many off-label purposes. However, since the drug is near patent expiration and the costs of trials are extremely high, it is assuredly unprofitable to try to prove its efficacy in traditional manners.

Many drugs have been marketed off label with no complaints. I think what the attorneys general would really like is some money to line their products, not drug reform.

[toddst]

Many drugs have been marketed off label with no complaints. I think what the attorneys general would really like is some money to line their products, not drug reform.

You are exactly right. If the cost of trials were reduced and new applications of the drug allowed for extension of patents, the situation would change.

[jrg]

My son has epilepsy and we are constantly trying new drugs in an attempt to control it. Neurontin turned this child into Damien...Uncontrollable rages,suicidal tendencies, etc. (in an 8 year old at the time). When weaned off this drug, he returned to his normal self...Personally, I'm not a big fan of Neurontin, but these kinds of medicines affect people in different ways...
As an aside, even with insurance, we pay a FORTUNE monthly in medical costs....I believe we'd do better buying drugs off the street.